Related Experiment Video

Updated: Aug 15, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Impact of ventilator-associated pneumonia on outcome in patients with COPD

Saad Nseir1, Christophe Di Pompeo, Stéphane Soubrier

  • 1Intensive Care Unit, Calmette Hospital, Regional University Centre, Lille II University, France. s-nseir@chru-lille.fr

Chest
|September 16, 2005
PubMed
Abstract

Insights

Ventilator-associated pneumonia (VAP) significantly increases ICU mortality, mechanical ventilation duration, and hospital stay in patients with chronic obstructive pulmonary disease (COPD). Early VAP detection and management are crucial for improving patient outcomes.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Infectious Diseases

Background:

  • Chronic obstructive pulmonary disease (COPD) patients are at increased risk for respiratory infections.
  • Ventilator-associated pneumonia (VAP) is a common complication in mechanically ventilated patients.
  • The impact of VAP on outcomes in COPD patients requires further investigation.

Purpose of the Study:

  • To determine the impact of ventilator-associated pneumonia (VAP) on outcomes in patients with COPD.
  • To assess the association between VAP and ICU mortality, duration of mechanical ventilation, and ICU length of stay.
  • To evaluate the effect of corticosteroid treatment on VAP outcomes in COPD patients.

Main Methods:

  • Prospective, observational, case-control study over 5 years in a 30-bed ICU.
  • Included COPD patients requiring mechanical ventilation (MV) for > 48 hours.
  • VAP diagnosed using clinical, radiographic, and quantitative microbiologic criteria; matched 1:1 for MV duration, age, SAPS II, and ICU admission category.

Main Results:

  • VAP developed in 6% of eligible COPD patients (n=77).
  • VAP was independently associated with increased ICU mortality (OR, 7.7; p < 0.001).
  • VAP patients experienced significantly longer MV duration and ICU stays compared to controls. Corticosteroid use in VAP patients was associated with lower mortality and shorter ICU stay.

Conclusions:

  • VAP significantly increases mortality rates in COPD patients.
  • VAP prolongs mechanical ventilation duration and ICU length of stay.
  • Corticosteroid treatment may improve outcomes for COPD patients with VAP.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: